Drug Utilization Review Annual Report
On an annual basis, states are required to report on their state’s prescribing habits, cost savings generated from their Drug Utilization Review (DUR) programs and their program’s operations, including adoption of new innovative DUR practices via the Medicaid Drug Utilization Review Annual Report Survey. Please visit the Drug Utilization Review page for more information. Please note that for FFY 2011 DUR reports, some of the information in the Tables 1 and 2 are not fully displayed due to the PDF format of the reports. To view complete information reported for these two tables, please click on Table 1 and Table 2.
For an overview of Medicaid Prescription Drug Programs visit the Prescription Drugs page.